Visalytics
Visalytics
approved EB-2 (NIW)

Senior Scientist

Pharmaceutical Sciences · India · 2021-12-20

Processing Time
13 days
Decision Date
2021-12-20
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop safe and effective drug delivery platforms, including lipid-based nanoparticles, extracellular vesicles, oral biotherapeutics, and hydrogels. This work utilizes techniques such as microfluidics and high-performance liquid chromatography to facilitate improved targeting and dosage for treating rheumatoid arthritis, diabetes, and cancer.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research into drug delivery for cancer and diabetes treatments holds significant merit and national importance for U.S. healthcare.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to a high citation record of 1,444 and a history of funding from the National Cancer Institute.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to pharmaceutical sciences justify a waiver of the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on 8 peer-reviewed journal articles and 4 international patent applications which garnered a massive 1,444 citations. Additionally, the petitioner completed 15 peer reviews for prestigious journals and secured major funding from the National Cancer Institute, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Assistant Professor

Pharmaceuticals · Syria

WeGreened EB-2 (NIW) approved
65 days 2022-03-23
The petitioner proposes to continue research in the development of new drug delivery carriers based on nanotechnology using a one-step reproducible process. This work focuses on developing DNA and RNA vaccines and treating diseases such as cancer, Alzheimer's, and diabetes. Additionally, the endeavor includes the development of new pediatric drugs designed to mask unpleasant tastes to ease ingestion for children.
View Case

Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
New Jersey 51 days 2025-03-17
The petitioner proposes to develop novel and advanced drug delivery systems for new drug products to support animal studies and clinical trials across a wide scope of treatment indications. His work specifically focuses on improving the bioavailability, precision, and controlled release of medications to address the global burden of cardiovascular diseases (CVDs).
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) rfe approved
North Carolina 111 days 2025-02-08
The petitioner proposes to improve existing therapies by applying advanced pharmaceutical principles to commercialize biopharmaceuticals and pharmaceuticals. The work focuses on developing innovative drug solubility enhancement methods and non-invasive oral drug delivery systems to treat serious diseases like cancer, AIDS, and kidney failure.
View Case

Postdoctoral Researcher

Chemicals · India

WeGreened EB-2 (NIW) approved
Massachusetts 156 days 2022-10-04
The petitioner proposes to continue research on developing state-of-the-art drug delivery approaches that cross biological interfaces. This work focuses on enabling the facile treatment of a wide range of disorders, including neurological disorders, metastatic cancer, and COVID-19, through protein-based therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2021-12-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 13 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist